Evidence map›Paper›PMID 31618886›Full record

ArticleInternational journal of molecular sciences2019

Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models.

Susana Proença, Bernardo Antunes, Rita C Guedes, Filipa Ramilo-Gomes, M Fátima Cabral, Judite Costa, Ana S Fernandes, Matilde Castro, Nuno G Oliveira, Joana P Miranda

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Susana ProençaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. s.proenca@uu.nl.
Bernardo AntunesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. bernardoantunes_94@hotmail.com.
Rita C GuedesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. rguedes@ff.ulisboa.pt.ORCID 0000-0002-5790-9181
Filipa Ramilo-GomesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. filipa.ramilo.gomes@tecnico.ulisboa.pt.ORCID 0000-0002-8498-593X
M Fátima CabralResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. fcabral@ff.ul.pt.
Judite CostaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. jcosta@ff.ul.pt.
Ana S FernandesCBIOS, University Lusófona, 1749-024 Lisbon, Portugal. ana.fernandes@ulusofona.pt.ORCID 0000-0001-6350-0641
Matilde CastroResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. mcastro@ff.ul.pt.
Nuno G OliveiraResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. ngoliveira@ff.ul.pt.
Joana P MirandaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. jmiranda@ff.ul.pt.
University of Lisbon · PTUniversidade Lusófona · PT

Funding

European Cooperation in Science and Technology CA16119 and CA16113Fundação para a Ciência e a Tecnologia UID/DTP/04138/2019, TUBITAK/003/2014, PTDC/TOX-MED/29183/2017, PD/BD/128320/2017
6 · The paper itself

Abstract

The role of metalloproteinases (MMPs) on the migration and invasion of cancer cells has been correlated with tumor aggressiveness, namely with the up-regulation of MMP-2 and 9. Herein, two pyridine-containing macrocyclic compounds, [15]pyN

Indexed as

Binding SitesCatalysisCell Line, TumorCell MovementCell ProliferationCell SurvivalFemaleHumansMacrocyclic CompoundsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsModels, MolecularMolecular StructureProtein BindingPyridinesMacrocyclic CompoundsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsPyridinesZinc3D modelsbreast cancermigration and invasionMMP inhibitorsmolecular docking studiespyridine-containing macrocyclic

Identifiers

PMID31618886
PMCPMC6829403
OpenAlexW2980588496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.